351 related articles for article (PubMed ID: 34956857)
1. MiRNAs as Anti-Angiogenic Adjuvant Therapy in Cancer: Synopsis and Potential.
Lahooti B; Poudel S; Mikelis CM; Mattheolabakis G
Front Oncol; 2021; 11():705634. PubMed ID: 34956857
[TBL] [Abstract][Full Text] [Related]
2. Angioregulatory microRNAs in breast cancer
Soheilifar MH; Masoudi-Khoram N; Madadi S; Nobari S; Maadi H; Keshmiri Neghab H; Amini R; Pishnamazi M
J Adv Res; 2022 Mar; 37():235-253. PubMed ID: 35499045
[TBL] [Abstract][Full Text] [Related]
3. Broad targeting of angiogenesis for cancer prevention and therapy.
Wang Z; Dabrosin C; Yin X; Fuster MM; Arreola A; Rathmell WK; Generali D; Nagaraju GP; El-Rayes B; Ribatti D; Chen YC; Honoki K; Fujii H; Georgakilas AG; Nowsheen S; Amedei A; Niccolai E; Amin A; Ashraf SS; Helferich B; Yang X; Guha G; Bhakta D; Ciriolo MR; Aquilano K; Chen S; Halicka D; Mohammed SI; Azmi AS; Bilsland A; Keith WN; Jensen LD
Semin Cancer Biol; 2015 Dec; 35 Suppl(Suppl):S224-S243. PubMed ID: 25600295
[TBL] [Abstract][Full Text] [Related]
4. Insights into the Regulation of Tumor Angiogenesis by Micro-RNAs.
Leone P; Buonavoglia A; Fasano R; Solimando AG; De Re V; Cicco S; Vacca A; Racanelli V
J Clin Med; 2019 Nov; 8(12):. PubMed ID: 31757094
[TBL] [Abstract][Full Text] [Related]
5. The Pleiotropic Effects of miRNAs on Tumor Angiogenesis.
Yin R; Guo L; Zhang W; Zheng J
J Cell Biochem; 2015 Sep; 116(9):1807-15. PubMed ID: 24115097
[TBL] [Abstract][Full Text] [Related]
6. Evading tumor evasion: current concepts and perspectives of anti-angiogenic cancer therapy.
Abdollahi A; Folkman J
Drug Resist Updat; 2010; 13(1-2):16-28. PubMed ID: 20061178
[TBL] [Abstract][Full Text] [Related]
7. Angiogenic signaling pathways and anti-angiogenic therapy for cancer.
Liu ZL; Chen HH; Zheng LL; Sun LP; Shi L
Signal Transduct Target Ther; 2023 May; 8(1):198. PubMed ID: 37169756
[TBL] [Abstract][Full Text] [Related]
8. Novel Angiogenic Regulators and Anti-Angiogenesis Drugs Targeting Angiogenesis Signaling Pathways: Perspectives for Targeting Angiogenesis in Lung Cancer.
Li Y; Lin M; Wang S; Cao B; Li C; Li G
Front Oncol; 2022; 12():842960. PubMed ID: 35372042
[TBL] [Abstract][Full Text] [Related]
9. Angioregulatory microRNAs in Colorectal Cancer.
Soheilifar MH; Grusch M; Neghab HK; Amini R; Maadi H; Saidijam M; Wang Z
Cancers (Basel); 2019 Dec; 12(1):. PubMed ID: 31887997
[TBL] [Abstract][Full Text] [Related]
10. Anti-angiogenic therapy as a cancer treatment paradigm.
Dhanabal M; Jeffers M; Larochelle WJ
Curr Med Chem Anticancer Agents; 2005 Mar; 5(2):115-30. PubMed ID: 15777219
[TBL] [Abstract][Full Text] [Related]
11. Dysregulation of the vascular endothelial growth factor and semaphorin ligand-receptor families in prostate cancer metastasis.
Bender RJ; Mac Gabhann F
BMC Syst Biol; 2015 Sep; 9():55. PubMed ID: 26341082
[TBL] [Abstract][Full Text] [Related]
12. Molecular diagnosis of tumor angiogenesis and anti-angiogenic cancer therapy.
Sato Y
Int J Clin Oncol; 2003 Aug; 8(4):200-6. PubMed ID: 12955574
[TBL] [Abstract][Full Text] [Related]
13. Angiogenesis in hepatocellular carcinoma: mechanisms and anti-angiogenic therapies.
Yao C; Wu S; Kong J; Sun Y; Bai Y; Zhu R; Li Z; Sun W; Zheng L
Cancer Biol Med; 2023 Jan; 20(1):25-43. PubMed ID: 36647777
[TBL] [Abstract][Full Text] [Related]
14. Therapeutics targeting angiogenesis: genetics and epigenetics, extracellular miRNAs and signaling networks (Review).
Katoh M
Int J Mol Med; 2013 Oct; 32(4):763-7. PubMed ID: 23863927
[TBL] [Abstract][Full Text] [Related]
15. Targeting tumor micro-environment for design and development of novel anti-angiogenic agents arresting tumor growth.
Gacche RN; Meshram RJ
Prog Biophys Mol Biol; 2013 Nov; 113(2):333-54. PubMed ID: 24139944
[TBL] [Abstract][Full Text] [Related]
16. Molecular regulation of tumor angiogenesis: mechanisms and therapeutic implications.
Harper J; Moses MA
EXS; 2006; (96):223-68. PubMed ID: 16383021
[TBL] [Abstract][Full Text] [Related]
17. MicroRNAs in tumor angiogenesis.
Wang W; Zhang E; Lin C
Life Sci; 2015 Sep; 136():28-35. PubMed ID: 26144623
[TBL] [Abstract][Full Text] [Related]
18. Anti-angiogenic Drug Resistance: Roles and Targeting of Non-coding RNAs (microRNAs and long non-coding RNAs).
Dashtaki ME; Ghasemi S
Curr Mol Pharmacol; 2023; 16(8):855-869. PubMed ID: 36475334
[TBL] [Abstract][Full Text] [Related]
19. Anti-Angiogenic Effects of Phytochemicals on miRNA Regulating Breast Cancer Progression.
Varghese E; Liskova A; Kubatka P; Mathews Samuel S; Büsselberg D
Biomolecules; 2020 Jan; 10(2):. PubMed ID: 32012744
[TBL] [Abstract][Full Text] [Related]
20. 'Accidental' anti-angiogenic drugs. anti-oncogene directed signal transduction inhibitors and conventional chemotherapeutic agents as examples.
Kerbel RS; Viloria-Petit A; Klement G; Rak J
Eur J Cancer; 2000 Jun; 36(10):1248-57. PubMed ID: 10882863
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
